radiotherapy

Open Access
Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC
MARIA BASSANELLI, SARA RAMELLA, MASSIMO ZEULI and ANNA CERIBELLI

Anticancer Research May 2022, 42 (5) 2241-2247; DOI: https://doi.org/10.21873/anticanres.15704
Open Access
Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer
ZACHARY S. MAYO, EVELYN O. ILORI, BRIAN MATIA, TIMOTHY D. SMILE, CHRISTOPHER W. FLEMING, CHANDANA A. REDDY, JOSEPH SCHARPF, ERIC D. LAMARRE, BRANDON L. PRENDES, JAMIE KU, BRIAN B. BURKEY, NIKHIL P. JOSHI, NEIL M. WOODY, SHLOMO A. KOYFMAN and SHAUNA R. CAMPBELL

Anticancer Research April 2022, 42 (4) 1845-1849; DOI: https://doi.org/10.21873/anticanres.15660
You have access
Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer
DIRK RADES, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and ELISA M. WERNER

Anticancer Research April 2022, 42 (4) 1973-1977; DOI: https://doi.org/10.21873/anticanres.15675
You have access
A Prognostic Tool to Estimate the Risk of Pneumonitis in Patients Irradiated for Lung Cancer
ESTHER GLATZEL, ELISA M. WERNER, SABINE BOHNET and DIRK RADES

Anticancer Research April 2022, 42 (4) 2029-2032; DOI: https://doi.org/10.21873/anticanres.15683
Open Access
Clinical Outcomes of Radiotherapy in Elderly and Younger Patients With T4 Esophageal Cancer: A Retrospective Single-center Analysis
YOSUKE TAKAKUSAGI, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, HIROYUKI KATOH, TADASHI KAMADA, RISA TANIUCHI, MISAKI IINO, TOMOMI AOSHIKA, SATOSHI SAITO and DAISAKU YOSHIDA

Anticancer Research April 2022, 42 (4) 2095-2104; DOI: https://doi.org/10.21873/anticanres.15691
You have access
Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer
MICHAEL C. JIN, Z. JASON QIAN and UCHECHUKWU C. MEGWALU

Anticancer Research March 2022, 42 (3) 1359-1365; DOI: https://doi.org/10.21873/anticanres.15605
You have access
Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy
CARSTEN NIEDER, BARD MANNSÅKER and ROSALBA YOBUTA

Anticancer Research March 2022, 42 (3) 1477-1480; DOI: https://doi.org/10.21873/anticanres.15618
You have access
Leptomeningeal Metastases of the Spine: A Systematic Review
PAOLO PALMISCIANO, NAVRAJ S. SAGOO, ABDURRAHMAN F. KHARBAT, YVES J. KENFACK, OTHMAN BIN ALAMER, GIANLUCA SCALIA, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER

Anticancer Research February 2022, 42 (2) 619-628; DOI: https://doi.org/10.21873/anticanres.15519
You have access
Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study
WON IL JANG, MI-SOOK KIM, JAE-HOON JEONG, WONWOO KIM and JAE SUNG KIM

Anticancer Research February 2022, 42 (2) 867-876; DOI: https://doi.org/10.21873/anticanres.15544
You have access
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI

Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559

Main menu

User menu

Search

radiotherapy

Pages